Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001348362-25-000014
Filing Date
2025-07-30
Accepted
2025-07-30 11:34:10
Documents
1
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 12240
  Complete submission text file 0001348362-25-000014.txt   13817
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 23 MIKELEN DRIVE PORT PERRY A6 L9L 1V1
Business Address
DOCHERTY JOHN MARTIN (Reporting) CIK: 0001638727 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39874 | Film No.: 251165144